Content about Pharmaceutics

April 22, 2012
Consumer care

A lot has happened across GlaxoSmithKline’s consumer division in the past year. Drug Store News spoke with GSK Consumer chief marketing officer John Graham and chief customer officer Keith Loranger about the next move to be made out of the consumer division’s new playbook.

May 18, 2012
Perrigo launches store-brand Prevacid 24HR

Perrigo on Friday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for lansoprazole capsules in the 15-mg strength.

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 15, 2012
GSK to buy up research and development company

GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

May 2, 2012
Sandoz acquires Fougera for $1.5 billion

Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

April 25, 2012
Amgen to buy Turkish drug maker for $700 million

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 24, 2012
Dr. Reddy's launches generic version of Zyprexa

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

April 23, 2012
Watson launches authorized generic diabetes drug

Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.

April 19, 2012
GPhA signs on with IMS Health to address drug shortages

A trade organization representing generic drug manufacturers announced Thursday its latest solution to the problem of drug shortages.

April 19, 2012
Watson seeks approval for generic Type 2 diabetes drug

Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.

April 18, 2012
Valeant buys product lines from Atlantis Pharma for $71 million

Valeant Pharmaceuticals International is acquiring "certain assets" of a drug maker based in Mexico.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

April 13, 2012
Lilly chief executive John Lechleiter appointed as PhRMA chairman

The Pharmaceutical Research and Manufacturers of America announced Friday the appointment of Eli Lilly chairman, president and CEO John Lechleiter as PhRMA chairman at its annual meeting.

April 11, 2012
Prasco to market authorized generic Vancocin

Prasco Labs will market an authorized generic version of a drug used to treat diarrhea caused by a bacterial infection, the company said Wednesday.

April 11, 2012
Takeda acquires URL Pharma

Takeda Pharmaceutical will acquire privately owned drug maker URL Pharma for $800 million, the companies said Wednesday.

April 9, 2012
Pfizer brings Lipitor marketing campaign to Walgreens Chicago flagship store

Drug maker Pfizer is taking a marketing campaign for one of its drugs to Walgreens' Chicago flagship store to raise awareness about high cholesterol and healthy eating, the company said Monday.

April 6, 2012
Par launches generic version of Provigil

Par Pharmaceutical has started shipping its generic version of a drug for sleep disorders, the company said Friday.

April 5, 2012
Teva entitled to exclusivity on Provigil, FDA decides

Teva is the first company to file for a generic version of a drug to treat sleep disorders, the Food and Drug Administration has determined.

April 3, 2012
Prestige Brands completes remainder of GSK OTC brands acquisition

Prestige Brands Holdings on Monday announced that it has completed the purchase of the two remaining brands of the 17 brands it agreed to acquire from GlaxoSmithKline; the purchase of Debrox ear wax remover and Gly-Oxide oral rinse completes the transaction.

April 3, 2012
Watson seeks approval for generic Lumigan, Latisse

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

April 2, 2012
Teva launches generic hypertension drugs

Teva Pharmaceutical Industries has launched generic versions of two blood pressure drugs made by Sanofi, Teva said Monday.

March 30, 2012
Teva launches authorized generic sleep disorder drug

Teva Pharmaceutical Industries has launched an authorized generic version of Cephalon's Provigil, used for conditions like shift work sleep disorder and narcolepsy, the company said Friday.

March 28, 2012
Three generic versions of psychiatric drug launched

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

March 26, 2012
Court dismisses AstraZeneca case against FDA

A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.

© 2012 Drug Store News. All Rights Reserved.